Our Services
Who We Serve
Resource Center
About Us
Decentralized Clinical Trials
Expanding Access, Enhancing Outcomes
Tailored support for virtual, hybrid, and traditional trials through Elligo’s flexible Decentralized Clinical Trial approach.
Our services
Everything You Need.
Nothing You Don’t.
Decentralized Clinical Trials
Driving Decentralized Trials From Start to Finish
Decentralized Clinical Trials expand access by blending in-person and remote participation, reducing barriers for patients while improving study efficiency. Elligo strengthens this model with the people, data, and infrastructure to make it work in the real world.
Our approach combines:
- Community-based access through the Elligo Site Network
- Data driven enrollment projections powered by EHR access
- Dedicated staff to drive study execution
- Physician oversight built on established patient relationships
Hybrid Clinical Trials
Adaptable Support Tailored to Your Protocol
Hybrid clinical trials blend in-person visits with remote and digital tools to broaden patient access, strengthen retention, and accelerate timelines.
Our hybrid model delivers:
- Flexible support scalable across any trial design
- Localized recruitment to engage diverse populations
- Consistent quality through unified SOPs and oversight
- Central team guidance for seamless site execution
Virtual Clinical Trials
Seamless Oversight for Fully Virtual Trials
Elligo delivers virtual trials that keep patients at the center. By extending beyond traditional site models, we expand access to diverse participants while maintaining safety, data integrity, and operational efficiency.
Our virtual model ensures:
- Experienced oversight with DOA to meet all regulatory requirements
- Consistent delivery of patient safety and reliable data across studies
- Centralized Team Support with Project Managers, Health Informatics, Medical Records, and Patient Engagement to drive efficiency and quality
- Proven success managing both high- and low-volume study enrollment
- Engaging patients where they are and at the right point in their healthcare journey
KEY BENEFITS
Proven Expertise. Adaptable Solutions.
With experience spanning every phase and model, Elligo delivers results that moves research forward with precision and impact.
Advancing Diagnostic Development
Supporting IVD and Medtech research with adaptable trial models, accelerated enrollment, and reliable study execution.
Accelerated Hybrid Trial Performance
Driving faster enrollment and stronger retention through centralized oversight, rapid start-up, and enhanced patient screening and support.
Diverse Therapeutic Experience
Executing studies with consistency and precision across a range of therapeutic areas—from endocrinology and neurology to general medicine and pulmonology.
Delivering Across All Study Stages
Proven trial execution spanning early and late stage development, post-market research, real-world evidence, and observational studies.
Diversity That Strengthens Research
Supporting sponsors and CROs to deliver more inclusive trials through trusted physicians and community connections.
By the numbers
Research Designed Around Your Needs
We integrate research directly into healthcare, delivering Decentralized Clinical Trials and enhancing physician and patient involvement through easier access and scalability of support.
90
%
Average Patient Retention
26
%
Diverse Patient Enrollment
40
+
Elligo Sites
0
Critical FDA Findings
Case Studies
Real-World Results
Accelerating Enrollment of 14,215 Participants
Direct-to-patient recruitment paired with Elligo central oversight reduced timelines from 2+ years to one.
Large-Scale Patient Enrollment, Delivered Quickly
Overachieved recruitment goals with enhanced patient engagement and expanded targeted recruitment strategies
Accelerated Performance for Phase 3 GLP-1 Trial
Investment in patient screening and enrollment experience drives higher patient retention alongside accelerated study performance.
Fast-Tracked Enrollment of 2,050 Patients for Cancer Detection Study
Early enrollment was achieved via multi-channel recruitment and rapid EHR prescreening.
Pharmacy Patient Identification and Home Visits for Diagnostics Test
Virtual model and at home sample collections accelerated patient recruitment.
Expanded Enrollment and Increased Study Oversight Utilizing Hybrid DCT Approach
Central PI oversight enabled fast participant identification and enrollment timelines maintained.
Enrollment and Diversity Goals Exceeded With DCT Approach
Elligo’s Clinical Research Center and Patient Engagement solutions combined to achieve study successes.
Contact us